[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Fragment-Based Drug Discovery Market Report 2019, Competitive Landscape, Trends and Opportunities

September 2019 | 120 pages | ID: G8592C0A5F39EN
Maia Research

US$ 2,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Fragment-Based Drug Discovery market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.

The report mainly studies the size, recent trends and development status of the Fragment-Based Drug Discovery market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Fragment-Based Drug Discovery market.

Major players in the global Fragment-Based Drug Discovery market include:
Sygnature Discovery
Sprint Bioscience
Alveus Pharmaceuticals Pvt. Ltd
Proteros Fragments GmbH
Structure Based Design, Inc
Emerald BioStructures, Inc
Evotec AG
Kinetic Discovery Limited
Astex Pharmaceuticals
Charles River Laboratories International, Inc
Beactica AB
Crown Bioscience, Inc

On the basis of types, the Fragment-Based Drug Discovery market is primarily split into:
NMR Spectroscopy
DSF Assay
Fluorescence Polarization (FP)
Isothermal Titration Calorimetry (ITC)
X-ray Crystallography

On the basis of applications, the market covers:
Biopharmaceutical Companies
CROs
Academic and Research Institutions

Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:
United States
Europe (Germany, UK, France, Italy, Spain, Russia, Poland)
China
Japan
India
Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)
Central and South America (Brazil, Mexico, Colombia)
Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)
Other Regions

Chapter 1 provides an overview of Fragment-Based Drug Discovery market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Fragment-Based Drug Discovery market by type, application, and region are also presented in this chapter.

Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.

Chapter 3 provides a full-scale analysis of major players in Fragment-Based Drug Discovery industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.

Chapter 4 gives a worldwide view of Fragment-Based Drug Discovery market. It includes production, market share revenue, price, and the growth rate by type.

Chapter 5 focuses on the application of Fragment-Based Drug Discovery, by analyzing the consumption and its growth rate of each application.

Chapter 6 is about production, consumption, export, and import of Fragment-Based Drug Discovery in each region.

Chapter 7 pays attention to the production, revenue, price and gross margin of Fragment-Based Drug Discovery in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.

Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.

Chapter 9 introduces the industrial chain of Fragment-Based Drug Discovery. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.

Chapter 10 provides clear insights into market dynamics.

Chapter 11 prospects the whole Fragment-Based Drug Discovery market, including the global production and revenue forecast, regional forecast. It also foresees the Fragment-Based Drug Discovery market by type and application.

Chapter 12 concludes the research findings and refines all the highlights of the study.

Chapter 13 introduces the research methodology and sources of research data for your understanding.

Years considered for this report:
  • Historical Years: 2014-2018
  • Base Year: 2019
  • Estimated Year: 2019
  • Forecast Period: 2019-2026
1 FRAGMENT-BASED DRUG DISCOVERY MARKET OVERVIEW

1.1 Product Overview and Scope of Fragment-Based Drug Discovery
1.2 Fragment-Based Drug Discovery Segment by Type
  1.2.1 Global Fragment-Based Drug Discovery Production and CAGR (%) Comparison by Type (2014-2026)
  1.2.2 The Market Profile of NMR Spectroscopy
  1.2.3 The Market Profile of DSF Assay
  1.2.4 The Market Profile of Fluorescence Polarization (FP)
  1.2.5 The Market Profile of Isothermal Titration Calorimetry (ITC)
  1.2.6 The Market Profile of X-ray Crystallography
1.3 Global Fragment-Based Drug Discovery Segment by Application
  1.3.1 Fragment-Based Drug Discovery Consumption (Sales) Comparison by Application (2014-2026)
  1.3.2 The Market Profile of Biopharmaceutical Companies
  1.3.3 The Market Profile of CROs
  1.3.4 The Market Profile of Academic and Research Institutions
1.4 Global Fragment-Based Drug Discovery Market by Region (2014-2026)
  1.4.1 Global Fragment-Based Drug Discovery Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)
  1.4.2 United States Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
  1.4.3 Europe Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.3.1 Germany Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.3.2 UK Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.3.3 France Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.3.4 Italy Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.3.5 Spain Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.3.6 Russia Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.3.7 Poland Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
  1.4.4 China Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
  1.4.5 Japan Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
  1.4.6 India Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
  1.4.7 Southeast Asia Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.7.1 Malaysia Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.7.2 Singapore Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.7.3 Philippines Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.7.4 Indonesia Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.7.5 Thailand Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.7.6 Vietnam Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
  1.4.8 Central and South America Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.8.1 Brazil Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.8.2 Mexico Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.8.3 Colombia Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
  1.4.9 Middle East and Africa Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.9.1 Saudi Arabia Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.9.2 United Arab Emirates Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.9.3 Turkey Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.9.4 Egypt Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.9.5 South Africa Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
    1.4.9.6 Nigeria Fragment-Based Drug Discovery Market Status and Prospect (2014-2026)
1.5 Global Market Size (Value) of Fragment-Based Drug Discovery (2014-2026)
  1.5.1 Global Fragment-Based Drug Discovery Revenue Status and Outlook (2014-2026)
  1.5.2 Global Fragment-Based Drug Discovery Production Status and Outlook (2014-2026)

2 GLOBAL FRAGMENT-BASED DRUG DISCOVERY MARKET LANDSCAPE BY PLAYER

2.1 Global Fragment-Based Drug Discovery Production and Share by Player (2014-2019)
2.2 Global Fragment-Based Drug Discovery Revenue and Market Share by Player (2014-2019)
2.3 Global Fragment-Based Drug Discovery Average Price by Player (2014-2019)
2.4 Fragment-Based Drug Discovery Manufacturing Base Distribution, Sales Area and Product Type by Player
2.5 Fragment-Based Drug Discovery Market Competitive Situation and Trends
  2.5.1 Fragment-Based Drug Discovery Market Concentration Rate
  2.5.2 Fragment-Based Drug Discovery Market Share of Top 3 and Top 6 Players
  2.5.3 Mergers & Acquisitions, Expansion

3 PLAYERS PROFILES

3.1 Sygnature Discovery
  3.1.1 Sygnature Discovery Basic Information, Manufacturing Base, Sales Area and Competitors
  3.1.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification
  3.1.3 Sygnature Discovery Fragment-Based Drug Discovery Market Performance (2014-2019)
  3.1.4 Sygnature Discovery Business Overview
3.2 Sprint Bioscience
  3.2.1 Sprint Bioscience Basic Information, Manufacturing Base, Sales Area and Competitors
  3.2.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification
  3.2.3 Sprint Bioscience Fragment-Based Drug Discovery Market Performance (2014-2019)
  3.2.4 Sprint Bioscience Business Overview
3.3 Alveus Pharmaceuticals Pvt. Ltd
  3.3.1 Alveus Pharmaceuticals Pvt. Ltd Basic Information, Manufacturing Base, Sales Area and Competitors
  3.3.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification
  3.3.3 Alveus Pharmaceuticals Pvt. Ltd Fragment-Based Drug Discovery Market Performance (2014-2019)
  3.3.4 Alveus Pharmaceuticals Pvt. Ltd Business Overview
3.4 Proteros Fragments GmbH
  3.4.1 Proteros Fragments GmbH Basic Information, Manufacturing Base, Sales Area and Competitors
  3.4.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification
  3.4.3 Proteros Fragments GmbH Fragment-Based Drug Discovery Market Performance (2014-2019)
  3.4.4 Proteros Fragments GmbH Business Overview
3.5 Structure Based Design, Inc
  3.5.1 Structure Based Design, Inc Basic Information, Manufacturing Base, Sales Area and Competitors
  3.5.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification
  3.5.3 Structure Based Design, Inc Fragment-Based Drug Discovery Market Performance (2014-2019)
  3.5.4 Structure Based Design, Inc Business Overview
3.6 Emerald BioStructures, Inc
  3.6.1 Emerald BioStructures, Inc Basic Information, Manufacturing Base, Sales Area and Competitors
  3.6.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification
  3.6.3 Emerald BioStructures, Inc Fragment-Based Drug Discovery Market Performance (2014-2019)
  3.6.4 Emerald BioStructures, Inc Business Overview
3.7 Evotec AG
  3.7.1 Evotec AG Basic Information, Manufacturing Base, Sales Area and Competitors
  3.7.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification
  3.7.3 Evotec AG Fragment-Based Drug Discovery Market Performance (2014-2019)
  3.7.4 Evotec AG Business Overview
3.8 Kinetic Discovery Limited
  3.8.1 Kinetic Discovery Limited Basic Information, Manufacturing Base, Sales Area and Competitors
  3.8.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification
  3.8.3 Kinetic Discovery Limited Fragment-Based Drug Discovery Market Performance (2014-2019)
  3.8.4 Kinetic Discovery Limited Business Overview
3.9 Astex Pharmaceuticals
  3.9.1 Astex Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Competitors
  3.9.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification
  3.9.3 Astex Pharmaceuticals Fragment-Based Drug Discovery Market Performance (2014-2019)
  3.9.4 Astex Pharmaceuticals Business Overview
3.10 Charles River Laboratories International, Inc
  3.10.1 Charles River Laboratories International, Inc Basic Information, Manufacturing Base, Sales Area and Competitors
  3.10.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification
  3.10.3 Charles River Laboratories International, Inc Fragment-Based Drug Discovery Market Performance (2014-2019)
  3.10.4 Charles River Laboratories International, Inc Business Overview
3.11 Beactica AB
  3.11.1 Beactica AB Basic Information, Manufacturing Base, Sales Area and Competitors
  3.11.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification
  3.11.3 Beactica AB Fragment-Based Drug Discovery Market Performance (2014-2019)
  3.11.4 Beactica AB Business Overview
3.12 Crown Bioscience, Inc
  3.12.1 Crown Bioscience, Inc Basic Information, Manufacturing Base, Sales Area and Competitors
  3.12.2 Fragment-Based Drug Discovery Product Profiles, Application and Specification
  3.12.3 Crown Bioscience, Inc Fragment-Based Drug Discovery Market Performance (2014-2019)
  3.12.4 Crown Bioscience, Inc Business Overview

4 GLOBAL FRAGMENT-BASED DRUG DISCOVERY PRODUCTION, REVENUE (VALUE), PRICE TREND BY TYPE

4.1 Global Fragment-Based Drug Discovery Production and Market Share by Type (2014-2019)
4.2 Global Fragment-Based Drug Discovery Revenue and Market Share by Type (2014-2019)
4.3 Global Fragment-Based Drug Discovery Price by Type (2014-2019)
4.4 Global Fragment-Based Drug Discovery Production Growth Rate by Type (2014-2019)
  4.4.1 Global Fragment-Based Drug Discovery Production Growth Rate of NMR Spectroscopy (2014-2019)
  4.4.2 Global Fragment-Based Drug Discovery Production Growth Rate of DSF Assay (2014-2019)
  4.4.3 Global Fragment-Based Drug Discovery Production Growth Rate of Fluorescence Polarization (FP) (2014-2019)
  4.4.4 Global Fragment-Based Drug Discovery Production Growth Rate of Isothermal Titration Calorimetry (ITC) (2014-2019)
  4.4.5 Global Fragment-Based Drug Discovery Production Growth Rate of X-ray Crystallography (2014-2019)

5 GLOBAL FRAGMENT-BASED DRUG DISCOVERY MARKET ANALYSIS BY APPLICATION

5.1 Global Fragment-Based Drug Discovery Consumption and Market Share by Application (2014-2019)
5.2 Global Fragment-Based Drug Discovery Consumption Growth Rate by Application (2014-2019)
  5.2.1 Global Fragment-Based Drug Discovery Consumption Growth Rate of Biopharmaceutical Companies (2014-2019)
  5.2.2 Global Fragment-Based Drug Discovery Consumption Growth Rate of CROs (2014-2019)
  5.2.3 Global Fragment-Based Drug Discovery Consumption Growth Rate of Academic and Research Institutions (2014-2019)

6 GLOBAL FRAGMENT-BASED DRUG DISCOVERY PRODUCTION, CONSUMPTION, EXPORT, IMPORT BY REGION (2014-2019)

6.1 Global Fragment-Based Drug Discovery Consumption by Region (2014-2019)
6.2 United States Fragment-Based Drug Discovery Production, Consumption, Export, Import (2014-2019)
6.3 Europe Fragment-Based Drug Discovery Production, Consumption, Export, Import (2014-2019)
6.4 China Fragment-Based Drug Discovery Production, Consumption, Export, Import (2014-2019)
6.5 Japan Fragment-Based Drug Discovery Production, Consumption, Export, Import (2014-2019)
6.6 India Fragment-Based Drug Discovery Production, Consumption, Export, Import (2014-2019)
6.7 Southeast Asia Fragment-Based Drug Discovery Production, Consumption, Export, Import (2014-2019)
6.8 Central and South America Fragment-Based Drug Discovery Production, Consumption, Export, Import (2014-2019)
6.9 Middle East and Africa Fragment-Based Drug Discovery Production, Consumption, Export, Import (2014-2019)

7 GLOBAL FRAGMENT-BASED DRUG DISCOVERY PRODUCTION, REVENUE (VALUE) BY REGION (2014-2019)

7.1 Global Fragment-Based Drug Discovery Production and Market Share by Region (2014-2019)
7.2 Global Fragment-Based Drug Discovery Revenue (Value) and Market Share by Region (2014-2019)
7.3 Global Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
7.4 United States Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
7.5 Europe Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
7.6 China Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
7.7 Japan Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
7.8 India Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
7.9 Southeast Asia Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
7.10 Central and South America Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
7.11 Middle East and Africa Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)

8 FRAGMENT-BASED DRUG DISCOVERY MANUFACTURING ANALYSIS

8.1 Fragment-Based Drug Discovery Key Raw Materials Analysis
  8.1.1 Key Raw Materials Introduction
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Manufacturing Cost Analysis
  8.2.1 Labor Cost Analysis
  8.2.2 Manufacturing Cost Structure Analysis
8.3 Manufacturing Process Analysis of Fragment-Based Drug Discovery

9 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

9.1 Fragment-Based Drug Discovery Industrial Chain Analysis
9.2 Raw Materials Sources of Fragment-Based Drug Discovery Major Players in 2018
9.3 Downstream Buyers

10 MARKET DYNAMICS

10.1 Drivers
10.2 Restraints
10.3 Opportunities
  10.3.1 Advances in Innovation and Technology for Fragment-Based Drug Discovery
  10.3.2 Increased Demand in Emerging Markets
10.4 Challenges
  10.4.1 The Performance of Alternative Product Type is Getting Better and Better
  10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices
10.5 Porter’s Five Forces Analysis
  10.5.1 Threat of New Entrants
  10.5.2 Threat of Substitutes
  10.5.3 Bargaining Power of Suppliers
  10.5.4 Bargaining Power of Buyers
  10.5.5 Intensity of Competitive Rivalry

11 GLOBAL FRAGMENT-BASED DRUG DISCOVERY MARKET FORECAST (2019-2026)

11.1 Global Fragment-Based Drug Discovery Production, Revenue Forecast (2019-2026)
  11.1.1 Global Fragment-Based Drug Discovery Production and Growth Rate Forecast (2019-2026)
  11.1.2 Global Fragment-Based Drug Discovery Revenue and Growth Rate Forecast (2019-2026)
  11.1.3 Global Fragment-Based Drug Discovery Price and Trend Forecast (2019-2026)
11.2 Global Fragment-Based Drug Discovery Production, Consumption, Export and Import Forecast by Region (2019-2026)
  11.2.1 United States Fragment-Based Drug Discovery Production, Consumption, Export and Import Forecast (2019-2026)
  11.2.2 Europe Fragment-Based Drug Discovery Production, Consumption, Export and Import Forecast (2019-2026)
  11.2.3 China Fragment-Based Drug Discovery Production, Consumption, Export and Import Forecast (2019-2026)
  11.2.4 Japan Fragment-Based Drug Discovery Production, Consumption, Export and Import Forecast (2019-2026)
  11.2.5 India Fragment-Based Drug Discovery Production, Consumption, Export and Import Forecast (2019-2026)
  11.2.6 Southeast Asia Fragment-Based Drug Discovery Production, Consumption, Export and Import Forecast (2019-2026)
  11.2.7 Central and South America Fragment-Based Drug Discovery Production, Consumption, Export and Import Forecast (2019-2026)
  11.2.8 Middle East and Africa Fragment-Based Drug Discovery Production, Consumption, Export and Import Forecast (2019-2026)
11.3 Global Fragment-Based Drug Discovery Production, Revenue and Price Forecast by Type (2019-2026)
11.4 Global Fragment-Based Drug Discovery Consumption Forecast by Application (2019-2026)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology
13.2 Research Data Source
LIST OF TABLES AND FIGURES

Figure Fragment-Based Drug Discovery Product Picture
Table Global Fragment-Based Drug Discovery Production and CAGR (%) Comparison by Type
Table Profile of NMR Spectroscopy
Table Profile of DSF Assay
Table Profile of Fluorescence Polarization (FP)
Table Profile of Isothermal Titration Calorimetry (ITC)
Table Profile of X-ray Crystallography
Table Fragment-Based Drug Discovery Consumption (Sales) Comparison by Application (2014-2026)
Table Profile of Biopharmaceutical Companies
Table Profile of CROs
Table Profile of Academic and Research Institutions
Figure Global Fragment-Based Drug Discovery Market Size (Value) and CAGR (%) (2014-2026)
Figure United States Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Europe Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Germany Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure UK Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure France Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Italy Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Spain Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Russia Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Poland Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure China Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Japan Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure India Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Southeast Asia Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Malaysia Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Singapore Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Philippines Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Indonesia Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Thailand Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Vietnam Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Central and South America Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Brazil Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Mexico Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Colombia Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Middle East and Africa Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Saudi Arabia Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure United Arab Emirates Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Turkey Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Egypt Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure South Africa Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Nigeria Fragment-Based Drug Discovery Revenue and Growth Rate (2014-2026)
Figure Global Fragment-Based Drug Discovery Production Status and Outlook (2014-2026)
Table Global Fragment-Based Drug Discovery Production by Player (2014-2019)
Table Global Fragment-Based Drug Discovery Production Share by Player (2014-2019)
Figure Global Fragment-Based Drug Discovery Production Share by Player in 2018
Table Fragment-Based Drug Discovery Revenue by Player (2014-2019)
Table Fragment-Based Drug Discovery Revenue Market Share by Player (2014-2019)
Table Fragment-Based Drug Discovery Price by Player (2014-2019)
Table Fragment-Based Drug Discovery Manufacturing Base Distribution and Sales Area by Player
Table Fragment-Based Drug Discovery Product Type by Player
Table Mergers & Acquisitions, Expansion Plans
Table Sygnature Discovery Profile
Table Sygnature Discovery Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
Table Sprint Bioscience Profile
Table Sprint Bioscience Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
Table Alveus Pharmaceuticals Pvt. Ltd Profile
Table Alveus Pharmaceuticals Pvt. Ltd Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
Table Proteros Fragments GmbH Profile
Table Proteros Fragments GmbH Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
Table Structure Based Design, Inc Profile
Table Structure Based Design, Inc Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
Table Emerald BioStructures, Inc Profile
Table Emerald BioStructures, Inc Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
Table Evotec AG Profile
Table Evotec AG Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
Table Kinetic Discovery Limited Profile
Table Kinetic Discovery Limited Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
Table Astex Pharmaceuticals Profile
Table Astex Pharmaceuticals Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
Table Charles River Laboratories International, Inc Profile
Table Charles River Laboratories International, Inc Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
Table Beactica AB Profile
Table Beactica AB Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
Table Crown Bioscience, Inc Profile
Table Crown Bioscience, Inc Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
Table Global Fragment-Based Drug Discovery Production by Type (2014-2019)
Table Global Fragment-Based Drug Discovery Production Market Share by Type (2014-2019)
Figure Global Fragment-Based Drug Discovery Production Market Share by Type in 2018
Table Global Fragment-Based Drug Discovery Revenue by Type (2014-2019)
Table Global Fragment-Based Drug Discovery Revenue Market Share by Type (2014-2019)
Figure Global Fragment-Based Drug Discovery Revenue Market Share by Type in 2018
Table Fragment-Based Drug Discovery Price by Type (2014-2019)
Figure Global Fragment-Based Drug Discovery Production Growth Rate of NMR Spectroscopy (2014-2019)
Figure Global Fragment-Based Drug Discovery Production Growth Rate of DSF Assay (2014-2019)
Figure Global Fragment-Based Drug Discovery Production Growth Rate of Fluorescence Polarization (FP) (2014-2019)
Figure Global Fragment-Based Drug Discovery Production Growth Rate of Isothermal Titration Calorimetry (ITC) (2014-2019)
Figure Global Fragment-Based Drug Discovery Production Growth Rate of X-ray Crystallography (2014-2019)
Table Global Fragment-Based Drug Discovery Consumption by Application (2014-2019)
Table Global Fragment-Based Drug Discovery Consumption Market Share by Application (2014-2019)
Table Global Fragment-Based Drug Discovery Consumption of Biopharmaceutical Companies (2014-2019)
Table Global Fragment-Based Drug Discovery Consumption of CROs (2014-2019)
Table Global Fragment-Based Drug Discovery Consumption of Academic and Research Institutions (2014-2019)
Table Global Fragment-Based Drug Discovery Consumption by Region (2014-2019)
Table Global Fragment-Based Drug Discovery Consumption Market Share by Region (2014-2019)
Table United States Fragment-Based Drug Discovery Production, Consumption, Export, Import (2014-2019)
Table Europe Fragment-Based Drug Discovery Production, Consumption, Export, Import (2014-2019)
Table China Fragment-Based Drug Discovery Production, Consumption, Export, Import (2014-2019)
Table Japan Fragment-Based Drug Discovery Production, Consumption, Export, Import (2014-2019)
Table India Fragment-Based Drug Discovery Production, Consumption, Export, Import (2014-2019)
Table Southeast Asia Fragment-Based Drug Discovery Production, Consumption, Export, Import (2014-2019)
Table Central and South America Fragment-Based Drug Discovery Production, Consumption, Export, Import (2014-2019)
Table Middle East and Africa Fragment-Based Drug Discovery Production, Consumption, Export, Import (2014-2019)
Table Global Fragment-Based Drug Discovery Production by Region (2014-2019)
Table Global Fragment-Based Drug Discovery Production Market Share by Region (2014-2019)
Figure Global Fragment-Based Drug Discovery Production Market Share by Region (2014-2019)
Figure Global Fragment-Based Drug Discovery Production Market Share by Region in 2018
Table Global Fragment-Based Drug Discovery Revenue by Region (2014-2019)
Table Global Fragment-Based Drug Discovery Revenue Market Share by Region (2014-2019)
Figure Global Fragment-Based Drug Discovery Revenue Market Share by Region (2014-2019)
Figure Global Fragment-Based Drug Discovery Revenue Market Share by Region in 2018
Table Global Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
Table United States Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
Table Europe Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
Table China Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
Table Japan Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
Table India Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
Table Southeast Asia Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
Table Central and South America Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
Table Middle East and Africa Fragment-Based Drug Discovery Production, Revenue, Price and Gross Margin (2014-2019)
Table Key Raw Materials Introduction of Fragment-Based Drug Discovery
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Market Concentration Rate of Raw Materials
Figure Manufacturing Cost Structure Analysis
Figure Manufacturing Process Analysis of Fragment-Based Drug Discovery
Figure Fragment-Based Drug Discovery Industrial Chain Analysis
Table Raw Materials Sources of Fragment-Based Drug Discovery Major Players in 2018
Table Downstream Buyers
Figure Global Fragment-Based Drug Discovery Production and Growth Rate Forecast (2019-2026)
Figure Global Fragment-Based Drug Discovery Revenue and Growth Rate Forecast (2019-2026)
Figure Global Fragment-Based Drug Discovery Price and Trend Forecast (2019-2026)
Table United States Fragment-Based Drug Discovery Production, Consumption, Export and Import Forecast (2019-2026)
Table Europe Fragment-Based Drug Discovery Production, Consumption, Export and Import Forecast (2019-2026)
Table China Fragment-Based Drug Discovery Production, Consumption, Export and Import Forecast (2019-2026)
Table Japan Fragment-Based Drug Discovery Production, Consumption, Export and Import Forecast (2019-2026)
Table India Fragment-Based Drug Discovery Production, Consumption, Export and Import Forecast (2019-2026)
Table Southeast Asia Fragment-Based Drug Discovery Production, Consumption, Export and Import Forecast (2019-2026)
Table Southeast Asia Fragment-Based Drug Discovery Production, Consumption, Export and Import Forecast (2019-2026)
Table Middle East and Africa Fragment-Based Drug Discovery Production, Consumption, Export and Import Forecast (2019-2026)
Table Global Fragment-Based Drug Discovery Market Production Forecast, by Type
Table Global Fragment-Based Drug Discovery Production Volume Market Share Forecast, by Type
Table Global Fragment-Based Drug Discovery Market Revenue Forecast, by Type
Table Global Fragment-Based Drug Discovery Revenue Market Share Forecast, by Type
Table Global Fragment-Based Drug Discovery Price Forecast, by Type
Table Global Fragment-Based Drug Discovery Market Production Forecast, by Application
Table Global Fragment-Based Drug Discovery Production Volume Market Share Forecast, by Application
Table Global Fragment-Based Drug Discovery Market Revenue Forecast, by Application
Table Global Fragment-Based Drug Discovery Revenue Market Share Forecast, by Application
Table Global Fragment-Based Drug Discovery Price Forecast, by Application


More Publications